

	BLANQUILT Trademark of Moseley, Annemarie B.. Serial Number: 78413833 :: Trademarkia Trademarks





























































Apply Online!
Attorneys

Services 

U.S. Trademark Registration Service 
International Trademark Registration Service 
Trademark Office Action Response 
Trademark Statement of Use 
Trademark Renewal 
Trademark Assignment 
Trademark Watch 
Trademark Cease & Desist  
Trademark Comprehensive Search  
Copyright Registration 
Patent Services 
Incorporation Services 
Business Page Creation 
 More Services... 


Help
Contact Us


Login






















Trademark Search 
Trademark Category
Fabrics
BLANQUILT










 
Get FREE email alerts













BLANQUILT  Trademark Information
 Moseley, Annemarie B.
Baby blankets and quilts




Perfect for these industries

Fabrics





Words that describe this mark
baby   blankets   quilts    
                                    




This is a brand page for the BLANQUILT trademark by Moseley, Annemarie B. 
                                in Austin, TX, 78733.
Write a review about a product or service associated with this BLANQUILT trademark.    
                                Or, contact the owner Moseley, Annemarie B. of the BLANQUILT trademark by filing a request to communicate with    
                                the Legal Correspondent for licensing, use, and/or questions related to the BLANQUILT trademark.
                           






On Thursday, May 6, 2004,  a U.S. federal trademark registration was filed for 
                        BLANQUILT by 
                        Moseley, Annemarie B., Austin, TX  78733.
                        The USPTO has given the BLANQUILT 
                        trademark serial  number of  78413833.  
                        The current federal status of this trademark filing is CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE.
                        The correspondent listed for BLANQUILT is 
                        
                        
                                            ANNEMARIE B. MOSELEY of 
                                            7913 Brightman Lane,  Austin TX 78733,  
                                .
                            The BLANQUILT trademark is filed in the category of 
                            
                                    Fabrics
                                . 
                            The description provided to the USPTO for BLANQUILT 
                            is Baby blankets and quilts. 
                            





Word mark:
 BLANQUILT


  Status/Status Date:  


CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE

2/12/2016



  Serial Number:  
78413833


  Filing Date:  
5/6/2004


 Registration Number:  
2965202 


 Registration Date:  
7/5/2005


 Goods and Services: 
Baby blankets and quilts


 Mark Description: 
NOT AVAILABLE


 Type Of Mark: 
TradeMark


 Published For Opposition Date: 
4/12/2005


Last Applicant/Owner:

Moseley, Annemarie B.Austin, TX  78733
Why is this contact information displayed?  

Why is this contact information displayed? [Close]
The USPTO makes this data available for search by the public so that individuals can locate ownership information for intellectual property, much the same way a county might make real estate property ownership information available.
Since our website is synchronized with the USPTO data, we recommend making any data changes with the USPTO directly. Our website will auto-update when the USPTO data is updated.
You may also contact Trademarkia to make a request for the removal of your personally identifiable information or trademark data.  Such requests must be made in writing and will be subject to verification of ownership.  This policy allows verified trademark owners to specify: (A) that their identifiable information be masked, or (B) that their trademark pages permanently deleted from Trademarkia.com.  
                                                Requests may be made directly to customer.service@trademarkia.com and every effort will be made to honor them within 48 hours. 
Click here for further details.
[Close]




 Mark Drawing Code:  
Standard Character Mark


 Design Search: 


(NO DATA)



Register Type:  
Principal


 Disclaimer:
 (NOT AVAILABLE)


 Correspondent:


ANNEMARIE B. MOSELEY
7913 Brightman Lane
Austin TX 78733







 Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.





Classification Information



Primary Class: 
 Class (024) - Textiles and textile goods, not included in other classes; beds and table covers. 


First Use Anywhere: 
1/11/2004


First Use In Commerce: 
4/30/2004





Trademarkia is the largest search engine for U.S. trademarks.  Each month hundreds of trademarks around the world are filed by licensed attorneys in the LegalForce/Trademarkia network! You can register your trademark in 170+ countries in the world through LegalForce Network.
 LegalForce Network can help you incorporate a business around your BLANQUILT trademark in less than 5 minutes.  Trademarkia makes the process easy and convenient, so start now!
 Trademarkia.com is a free search engine of publicly available government records.  Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.
Trademark Document Retrieval >>







Trademark - Apply Online!


100% Satisfaction Guarantee protect your valuable brand now.



How it works?
What you get?






1. Legalforce RAPC - #1 U.S. Trademark Filing from 2010 to now.
2. Describe how your business or product is being used. Register your mark in 176+ countries. Just $199 + govt fees! Start here >>






1. Top Global IP Attorneys - Credibility and Experience!
2. All processes will be performed in a timely manner. You will be informed periodically about the process.






Keep Track of this Brand.

 Trademark Watch Services
Keep track of how your trademark is being used. Available in the United States and in more than 176 countries. Round-the-clock monitoring. Monthly report on potential infringement.
                                

Watch this Trademark 

Trademark Watch Services read more...

Current Trademark Status:

2/12/2016
CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE


Free Trademark Search:






Correspondent Search:



ANNEMARIE B. MOSELEY


                                             
                                         is a correspondent of BLANQUILT trademark. 
                            	    


Current Overall Rating:

 (0 review)
                            
What You Can Do:




Start Your Business



FREE Logo Creator



Add to Favorites



View Documents



FREE Trademark Search



Start Trademark Filing Process



Protect this Mark Internationally



Custom Logo Design $159



Search blanquilt on popular social networks






                                Trademarkia lets you see how your 
                                personal name, product name, 
                                trademark name or username is being used on any of 530+ new 
                                and popular social networks.  
                                Be the first to reserve your name  and get help stopping others from using it - all in one place!















Trademark Oppose Service


You can request for Extension of Time to Oppose this mark or Oppose it now.



                 - If you are new to LegalForce/Trademarkia, please just enter your contact email and create a password;
                 

                 - If you already have a LegalForce/Trademarkia account, please enter your account's email and password.
                


* Email Address: 


 Please enter your email address



* Enter Password: 


 Please enter your password



* 



 Please enter the value




 

  
                             



 







Status Update Alerts

Status Update Alerts are email updates of the latest trademark status change. Please make sure you provide the correct email. 


                 - If you are new to LegalForce/Trademarkia, please just enter your contact email and create a password;
                 

                 - If you already have a LegalForce/Trademarkia account, please enter your account's email and password.
                


* Email Address: 


 Please enter your email address



* Enter Password: 


 Please enter your password



* 



 Please enter the value




 

  
                             



 









Review & Rating

Please Rate and Review for BLANQUILT 




BLANQUILT is providing Baby blankets and quilts.
                


                 - If you are new to LegalForce/Trademarkia, please just enter your contact email and create a password to be associated with your review.
                 

                 If you already have a LegalForce/Trademarkia account, please enter your account's email and password before posting your review.
                 


* Please Rate: 


     




* Your Review: 



 Please enter your review.



* Email Address: 


 Please enter your email address



* Enter Password: 


 Please enter your password



 

  
                             



 
























Annemarie Moseley - Osiris Therapeutics - The Wall Street Transcript














































 






































Healthcare >> CEO Interviews >> October 12, 2001 Annemarie Moseley – Osiris Therapeutics
ANNEMARIE B. MOSELEY, has been President and Chief Executive Officer of
Osiris Therapeutics since the fourth quarter of 1999. Prior to her
current position at the company, Dr. Moseley served Osiris as Sr. Vice
President of Clinical and Regulatory Affairs. Before joining Osiris, Dr.
Moseley served as Director of Clinical Gene Therapy at SyStemix, a
Novartis company, where she was responsible for clinical development of
HIV stem cell gene therapy. Before that, she held the position of Sr.
Vice President of Clinical/Regulatory Affairs for Titan Pharmaceuticals,
Inc., and Applied Immune Sciences, a subsidiary of Rhone Poulenc Rohrer.
Her responsibilities included the clinical and regulatory management of
programs in cellular and gene therapy products for cancer and infectious
diseases. Dr. Moseley received a Ph.D. in Physiology and Biochemistry
from Utah State University and an MD from Baylor College of Medicine,
where she completed a residency in Internal Medicine, a clinical
investigator program in Immunology, and a clinical stem cell gene
therapy fellowship in Medical and Molecular Genetics. Profile


TWST: Can we start out with a history and overview of Osiris?Dr. Moseley: Osiris is a privately held biotechnology company that wasfounded in early 1993. Our primary technology is based on
    

Join for free to read a longer excerpt or purchase this article

Already a member? Login here 









CartLatest NewsAll American USC Footbal Player Joseph M. Boskovich Jr. Now Picks All American Value Stocks for his ClientsPaul Hogan Picks Tech Dividend Growers Microchip Technology (NASDAQ:MCHP), Xilinx (NASDAQ:XLNX) and Versum Materials (NYSE:VSM)600 Gallons of Water to Produce a McDonalds (NYSE:MCD) Quarter Pounder:  How Will Investors Profit?The Wall Street Transcript is a completely unique resource for investors and business researchers.Over 20,000 CEO, Equity Analyst and Money Manager InterviewsSubscribe now!Sign Up For Newsletter Weekly email with New In-Depth Interviews


Email: 



Most Popular InterviewsProtecting Assets Through a Rules-Based FundPaula R. Wieck Published July 24, 2017 in Investing StrategiesBuy ($25)Managing Risk Through Strict Quality StandardsJeffrey P. CornellMichael S. Jordan Published July 24, 2017 in Investing StrategiesCompanies covered: AAPL GOOG SAP NSRGY Buy ($25)Identifying Emerging-Market and International Stocks with a Bottom-Up ProcessRahul  Sharma Published July 24, 2017 in Investing StrategiesCompanies covered: 600690 GE ASX TSM HDFC LUKOY XOM TOT RDS/A IBULHSGFIN ARCLK Buy ($25)Most Popular ReportsInvesting Strategies Published July 24, 2017Buy ($175)Wireless Communications & Telecom Published July 14, 2017Buy ($175)Investing Strategies Published July 11, 2017Buy ($175) 






Top Company Interviews






Register for a Free Account to gain greater access to
            The Wall Street Transcript right now




CEO INTERVIEWSInterview with the President and CEO: Lumos Networks Corp. (NASDAQ:LMOS)Interview with the Corporate VP of Business Development, Strategy and Investor Relations: DSP Group, Inc. (NASDAQ:DSPG)Interview with the CEO and Director: Tactile Systems Technology, Inc. (NASDAQ:TCMD) 

SECTOR ROUNDTABLESNatural Gas Weighs Heavy On E&P Near-Term ProspectsRoundtable Forum:optimism Despite Uncertainty In For-profit EducationRoundtable Forum:a Shift In Focus To Natural Gas From Oil 

MONEY MANAGER INTERVIEWSProtecting Assets Through a Rules-Based FundManaging Risk Through Strict Quality StandardsIdentifying Emerging-Market and International Stocks with a Bottom-Up Process 

ANALYST INTERVIEWSAnalyzing the Secular Drivers Within Communications Infrastructure and TelecomSatellite Companies Benefiting from Growth in Data TrafficIncreased Focus on Content as Consumers Shift to Digital Consumption 




Subscribe Today!







                Since 1963
                © The Wall Street Transcript 1997-2016
Terms and Conditions
Privacy Policy  
            





https://www.twst.com/wp-admin/admin-ajax.php

Pin It on Pinterest





































Share This





Twitter





Facebook





Google+





Gmail





LinkedIn








































×





Join now for free!
Already a member?






First Name 





Last Name 





Email address *








Create new account
 


or create an account with a social network.

Join with Facebook


Join with Twitter


Join with Google








Username or Email address: *





Password: *






LoginJoin now! | Forgot password?
 


or login using a social network


Log in with Facebook


Log in with Twitter


Log in with Google


















Moseley, Annemarie B. - The Wall Street Transcript











































 





































Annemarie B. Moseley
ANNEMARIE B. MOSELEY, has been President and Chief Executive Officer of
Osiris Therapeutics since the fourth quarter of 1999. Prior to her
current position at the company, Dr. Moseley served Osiris as Sr. Vice
President of Clinical and Regulatory Affairs. Before joining Osiris, Dr.
Moseley served as Director of Clinical Gene Therapy at SyStemix, a
Novartis company, where she was responsible for clinical development of
HIV stem cell gene therapy. Before that, she held the position of Sr.
Vice President of Clinical/Regulatory Affairs for Titan Pharmaceuticals,
Inc., and Applied Immune Sciences, a subsidiary of Rhone Poulenc Rohrer.
Her responsibilities included the clinical and regulatory management of
programs in cellular and gene therapy products for cancer and infectious
diseases. Dr. Moseley received a Ph.D. in Physiology and Biochemistry
from Utah State University and an MD from Baylor College of Medicine,
where she completed a residency in Internal Medicine, a clinical
investigator program in Immunology, and a clinical stem cell gene
therapy fellowship in Medical and Molecular Genetics.
Related Interviews:Annemarie Moseley - Osiris TherapeuticsOctober 12, 2001







CartLatest NewsAll American USC Footbal Player Joseph M. Boskovich Jr. Now Picks All American Value Stocks for his ClientsPaul Hogan Picks Tech Dividend Growers Microchip Technology (NASDAQ:MCHP), Xilinx (NASDAQ:XLNX) and Versum Materials (NYSE:VSM)600 Gallons of Water to Produce a McDonalds (NYSE:MCD) Quarter Pounder:  How Will Investors Profit?The Wall Street Transcript is a completely unique resource for investors and business researchers.Over 20,000 CEO, Equity Analyst and Money Manager InterviewsSubscribe now!Sign Up For Newsletter Weekly email with New In-Depth Interviews


Email: 



Most Popular InterviewsProtecting Assets Through a Rules-Based FundPaula R. Wieck Published July 24, 2017 in Investing StrategiesBuy ($25)Managing Risk Through Strict Quality StandardsJeffrey P. CornellMichael S. Jordan Published July 24, 2017 in Investing StrategiesCompanies covered: AAPL GOOG SAP NSRGY Buy ($25)Identifying Emerging-Market and International Stocks with a Bottom-Up ProcessRahul  Sharma Published July 24, 2017 in Investing StrategiesCompanies covered: 600690 GE ASX TSM HDFC LUKOY XOM TOT RDS/A IBULHSGFIN ARCLK Buy ($25)Most Popular ReportsInvesting Strategies Published July 24, 2017Buy ($175)Wireless Communications & Telecom Published July 14, 2017Buy ($175)Investing Strategies Published July 11, 2017Buy ($175) 






Top Company Interviews






Register for a Free Account to gain greater access to
            The Wall Street Transcript right now




CEO INTERVIEWSInterview with the President and CEO: Lumos Networks Corp. (NASDAQ:LMOS)Interview with the Corporate VP of Business Development, Strategy and Investor Relations: DSP Group, Inc. (NASDAQ:DSPG)Interview with the CEO and Director: Tactile Systems Technology, Inc. (NASDAQ:TCMD) 

SECTOR ROUNDTABLESNatural Gas Weighs Heavy On E&P Near-Term ProspectsRoundtable Forum:optimism Despite Uncertainty In For-profit EducationRoundtable Forum:a Shift In Focus To Natural Gas From Oil 

MONEY MANAGER INTERVIEWSProtecting Assets Through a Rules-Based FundManaging Risk Through Strict Quality StandardsIdentifying Emerging-Market and International Stocks with a Bottom-Up Process 

ANALYST INTERVIEWSAnalyzing the Secular Drivers Within Communications Infrastructure and TelecomSatellite Companies Benefiting from Growth in Data TrafficIncreased Focus on Content as Consumers Shift to Digital Consumption 




Subscribe Today!







                Since 1963
                © The Wall Street Transcript 1997-2016
Terms and Conditions
Privacy Policy  
            





https://www.twst.com/wp-admin/admin-ajax.php

Pin It on Pinterest





































Share This





Twitter





Facebook





Google+





Gmail





LinkedIn








































×





Join now for free!
Already a member?






First Name 





Last Name 





Email address *








Create new account
 


or create an account with a social network.

Join with Facebook


Join with Twitter


Join with Google








Username or Email address: *





Password: *






LoginJoin now! | Forgot password?
 


or login using a social network


Log in with Facebook


Log in with Twitter


Log in with Google
















Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version

















Annemarie B. Moseley - Chief Operating Officer & Executive Vice President of Clinical Development at Bellicum Pharmaceuticals Inc.



























































                      NEWS HOME
                    

Advertising
Board and Executive Moves
Energy
Health Care
Hedge Funds
M & A
Private Equity
Technology








            You have  
            
9 free profiles

              left this month   
			      

                Start Your Free Trial ➤
              








            Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there?
            

                View on RelSci Pro ➤
              




























































































































Email







LinkedIn







Facebook







Google+







Tweet







Reddit





Permalink





Annemarie B. Moseley
Chief Operating Officer & Executive Vice President of Clinical Development at Bellicum Pharmaceuticals Inc.



Overview
In The News Relationships Paths
Education Career History Boards & Committees Investments Public Holdings Transactions 


Annemarie B. Moseley
Chief Operating Officer & Executive Vice President of Clinical Development at Bellicum Pharmaceuticals Inc.



 Overview



Age



61
                                  (Born 1956)
                                              




Notable Companies


Repair Technologies, Inc.

Osiris Therapeutics, Inc.

Cognate BioServices, Inc.




Board Seats



2





Number of Relationships



                This person is connected to 594 people.
              






 In The News
          See more




GlobeNewswire
May 15, 2017





                        Bellicum Pharmaceuticals Announces Management Changes                    







 Relationships
              See Details




Kenneth Ray Moseley

Corporate Secretary, Senior Vice President & General Counsel at Bellicum Pharmaceuticals Inc.




Alan K. Smith

Executive Vice President, Technical Operations at Bellicum Pharmaceuticals Inc.





Joseph Howard Senesac

Vice President-Viral Vector Development at Bellicum Pharmaceuticals Inc.




Alan A. Musso

Chief Financial Officer & Treasurer at Bellicum Pharmaceuticals Inc.





George Adams

President, Chief Executive Officer, Director & Head-Investor Relations at Ventripoint Diagnostics Ltd.




Philip M. Toleikis

President, Chief Executive Officer, Director at Sernova Corp.





Jeffrey A. Bacha

Co-Founder at DelMar Pharmaceuticals, Inc.




Hans J. Mäder

Vice President, Site Manufacturing at Acrimax





David M. Spencer

Co-Founder at Bellicum Pharmaceuticals Inc.




Kevin M. Slawin

Member at The Center For Clinical Research Practice







See 584 more listings with RelSci Professional.

Start My Free Trial ➤








See 584 More 


 


 Paths to Annemarie B. Moseley



            Annemarie B. Moseley          




 You



 Connections via Relationship Science



 Annemarie B. Moseley






Sync your contacts to see how you can connect with Annemarie B. Moseley.

Start My Free Trial ➤








See  More 


 


 Educational Background



 


The University of Texas at Austin

                  The University of Texas at Austin is one of the largest public universities in the United States and is the largest institution of The University of Texas System. Founded in 1883, the university has grown from a single building, eight teachers, two departments and 221 students to a 350-acre main campus with 17 colleges and schools, about 24,000 faculty and staff, and more than 50,000 students.                




Ph.D Physiology/Biochemistry 


Utah State University

                  Utah State University (USU) is a public research university in Logan, Utah. Founded in 1888 as Utah's agricultural college, USU focused on agriculture, domestic arts, and mechanic arts. The university now offers programs in liberal arts, engineering, business, economics, natural resource sciences, as well as nationally ranked elementary & secondary education programs. The university has eight colleges and offers a total of 176 bachelor's degrees, 97 master's degrees, and 38 doctoral degrees. It is a land-grant and space-grant institution accredited by the Northwest Commission on Colleges and Universities.

USU's main campus is located in Logan with regional campuses in Brigham City, Tooele, and the Uintah Basin. In 2010, the College of Eastern Utah, located in Price, Utah joined the USU system becoming Utah State University College of Eastern Utah (USU Eastern). Throughout Utah, USU operates more than 20 distance education centers. Regional campuses, USU Eastern, and distance education centers provide degrees to more than 40% of the students enrolled. In total, USU has more than 180,000 alumni in all 50 states and more than 100 countries.

With more than 16,000 students living on or near campus, USU is the largest public residential campus in Utah.

USU's athletic teams compete in Division I of the NCAA and are collectively known as the Utah State Aggies. They are members of the Mountain West Conference.                




MD 


Baylor College of Medicine

                  Baylor College of Medicine in Houston was formed in 1990 and its known for excellence in education, research and patient care.                





 Career History



Chief Operating Officer & Executive Vice President of Clinical Development

                                    2011 - 2017                


Bellicum Pharmaceuticals Inc.


                  Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. It's proprietary chemical induction of dimerization technology engineers and controls components of the immune system. The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX.                




Genetics Fellow

                                    Current                


Baylor College of Medicine


                  Baylor College of Medicine in Houston was formed in 1990 and its known for excellence in education, research and patient care.                




Chairman & Chief Executive Officer

                                    2004 - Prior                


Repair Technologies, Inc.






Co-Founder

                                    2002 - Prior                


Cognate BioServices, Inc.


                  Cognate BioServices, Inc. manufactures cell-based therapeutics products. It provides services in the areas of preclinical research, assay development, regulatory services, process development and cGMP cell-based manufacturing. The firm offers a range of analytical test methods, development and testing services for cell-based products. The company was founded in 2002 and is headquartered in Hanover, MD.                




Vice President-Clinical Research

                                    1992 - 1995                


Applied Immune Sciences, Inc.


                  Part of Sanofi, Applied Immune Sciences, Inc. is an American company located in Menlo Park, CA, specializing in surgical and medical instruments and apparatus. The firm was founded by Thomas B. Okarma. Applied Immune Sciences, Inc. was acquired by Rhone-Poulenc Rorer, Inc. on 28 Nov 95 for $84.40 million.                




Chief Executive Officer

                                    Prior                


Osiris Therapeutics, Inc.


                  Osiris Therapeutics, Inc. engages in stem cell research and development of pharmaceutical products. Its regenerative medicine targets dermal burns, pressure ulcers, venous leg, diabetic foot ulcers, as well as tissue and bone repair. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD.                




Director-Clinical Gene Therapy

                                    Prior                


Systemix, Inc.


                  Systemix, Inc., part of Novartis AG, is an American company located in Palo Alto, CA. The firm develops cell-based gene therapies for diseases. It was founded by Irving L. Weissman and Leroy E. Hood. Linda D. Sonntag is currently the CEO of the company. Novartis AG acquired Systemix, Inc. on 14 Feb 97 for $75.90 million.                




Professional

                                    Prior                


Novartis AG


                  Novartis AG develops, manufactures, and markets healthcare products. It operates through the following segments: Pharmaceuticals, Alcon, Sandoz, and Corporate Activities. The Pharmaceuticals segment provides patent-protected prescription medicines. The Alcon segment offers surgical, ophthalmic pharmaceuticals, and vision care products. The Sandoz segment supplies generic pharmaceuticals. The Corporate Activities segment includes other items of income and expense which are not attributable to specific segments such as certain expenses related to post-employment benefits, environmental remediation liabilities, charitable activities, donations, and sponsorships. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.                




Professional

                                    Prior                


Guidant Sales Corp.


                  Guidant Corporation is engaged in the design and manufacture of cardiovascular medical products. It is operating as a part off Boston Scientific and Abbott Labs, manufacturing artificial cardiac pacemakers,implantable cardioverter-defibrillators, stents, and more.


Its medical devices help patients with heart diseases in returning to active and productive lives and physicians for improving patient management and clinical outcomes.


Guidant Corporation is headquartered in Indianapolis, Indiana and was founded in 1994.                




Professional

                                    Prior                


Novartis Corporation


                  Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded in 1996 and is headquartered in New York, NY.                




Professional

                                    Prior                


Guidant Corporation


                  Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN.                




Professional

                                    Prior                


Rhone-Poulenc Rorer, Inc.


                  Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA.                





 Boards & Committees



Corporate Boards ▾




Director

                    2009 - Prior                  


Sernova Corp.

                    Sernova Corp. is a clinical stage regenerative medicine company. It engages in the business of developing medical technologies for the treatment of chronic debilitating metabolic diseases such as diabetes, blood disorders including haemophilia and other diseases treated through replacement of proteins and hormones missing within the body. The company also focuses in the manufacture and clinical evaluation of the cell pouch for insulin-dependent diabetes. Sernova was founded in 1992 and is headquartered in London, Canada.                  




Chairman & Chief Executive Officer

                    2004 - Prior                  


Repair Technologies, Inc.







 Investments



 Details Hidden


Cognate BioServices, Inc.

                  Cognate BioServices, Inc. manufactures cell-based therapeutics products. It provides services in the areas of preclinical research, assay development, regulatory services, process development and cGMP cell-based manufacturing. The firm offers a range of analytical test methods, development and testing services for cell-based products. The company was founded in 2002 and is headquartered in Hanover, MD.                





 Public Holdings






Restricted data only for RelSci Professional users.

Start My Free Trial ➤








See  More 


 


 Transactions



 Details Hidden



                  Bellicum Pharmaceuticals Inc. raised money in a private placement transaction                                  




 Details Hidden



                  Bellicum Pharmaceuticals Inc. raised money in a private placement transaction                                  





 Other Affiliations




              Annemarie B. Moseley is affiliated with
                            Bellicum Pharmaceuticals Inc., Baylor College of Medicine, Repair Technologies, Inc., Cognate BioServices, Inc., Applied Immune Sciences, Inc., Osiris Therapeutics, Inc., Systemix, Inc., Novartis AG, Guidant Sales Corp., Novartis Corporation, Guidant Corporation, Rhone-Poulenc Rorer, Inc., Sernova Corp., Repair Technologies, Inc..
            





You've reached your 10 free profiles limit this month.
Upgrade to RelSci Pro today to enjoy unlimited article views and much more!

Start My Free Trial  ➤

Still not convinced? Check out our full listing of features here.












Are you a RelSci Pro Subscriber?

Login to RelSci Pro 
                        ➤


Not a Pro Subscriber? Log in here to manage your alerts









 Keep me signed in.
        

Login  ➤



        Forgot your Password?
    

























 I have read the LexisNexis terms & conditions




Sign Me Up  ➤















    Annemarie Moseley | Osiris Therapeutics , Inc. | ZoomInfo.com    Annemarie Moseley | Osiris Therapeutics , Inc. | ZoomInfo.com